Clinical Trials Browser

Completed × Stomach Neoplasms × apatinib × Clear all

NCT03813784 2025-09-16

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

NCT03878472 2024-12-16

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT03472365 2024-01-11

A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

Phase 2 Completed

67 enrolled 12 charts

Gastrointestinal

Stomach Neoplasms

NCT05025033 2023-01-18

Chemotherapy Combined With Apatinib and PD-1 Antibody

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT02711969 2022-07-22

A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment

Phase 1 Completed

Gastrointestinal

Stomach Neoplasms

NCT03104283 2022-03-15

Apatinib for the Elderly Advanced Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT02764268 2022-03-11

Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

NCT04338438 2020-11-10

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT03384511 2018-02-20

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Phase 4 Completed

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01512745 2016-10-17

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Phase 3 Completed

267 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

NCT00970138 2011-07-12

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms